Consilium Wealth Advisory’s Boston Scientific BSX Stock Holding History

Consilium Wealth Advisory’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11,620	Closed	-$1.11M	–	105
2025 Q4	$1.11M	Buy	11,620 +341	+3%	+$33.4K	0.41%	39
2025 Q3	$1.1M	Sell	11,279 -2,187	-16%	-$226K	0.42%	39
2025 Q2	$1.45M	Buy	13,466 +120	+0.9%	+$12.1K	0.61%	29
2025 Q1	$1.35M	Buy	13,346 +1,130	+9%	+$114K	0.67%	34
2024 Q4	$1.09M	Buy	12,216 +5,937	+95%	+$523K	0.52%	38
2024 Q3	$526K	Buy	6,279 +263	+4%	+$20.7K	0.29%	55
2024 Q2	$463K	Buy	+6,016	New	+$440K	0.25%	58

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Consilium Wealth Advisory's BSX Position: Q1 2026 in Review

Consilium Wealth Advisory sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 11,620 shares — an estimated $1.11M sold.

Consilium Wealth Advisory first reported a position in BSX in Q2 2024 and held it in 7 quarters. The position peaked at $1.45M in Q2 2025. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Consilium Wealth Advisory reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Consilium Wealth Advisory sold 11,620 Boston Scientific shares in Q1 2026, an estimated $1.11M.
Consilium Wealth Advisory first reported a position in Boston Scientific in Q2 2024 and held it in 7 quarters.
Consilium Wealth Advisory's Boston Scientific position peaked at $1.45M in Q2 2025.
1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Consilium Wealth Advisory's 13F filing for Q1 2026, filed 20 Apr 2026.